Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Libeny
- Development stage
- Unknown
- Lead developer
- Nucitec
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Libeny is an oral multivitamin and mineral syrup developed and marketed by Nucitec in Mexico. It is formulated with a combination of essential vitamins and minerals, including vitamin A (retinol), vitamin D2 (ergocalciferol), vitamin E (tocopherol), vitamin B1 (thiamine), vitamin B2 (riboflavin), vitamin B3 (niacinamide), vitamin B6 (pyridoxine), vitamin B12 (cyanocobalamin), vitamin C (ascorbic acid), and iron (as ferrous sulfate). Libeny is indicated for the prevention and treatment of vitamin and mineral deficiencies, particularly in pediatric populations, supporting overall growth, immune function, and metabolic health.
- Brand names
- Libeny
- Other names
- Libeny Jarabe
Beyond the preview
Go deeper on Libeny.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Libeny.